Ko e hā e ʻuhinga ʻo e “Mahino”?
‘Oku ‘ikai ke ‘ave ‘e he manú ‘a e mutation. He ʻikai ke ne maʻu ʻa e mahakí . pea ‘e ‘ikai te ne paasi atu ia.
The Canine Multiple System Degeneration (CMSD) DNA test is essential for Kerry Blue Terrier owners to ensure their dogs' health. CMSD is a hereditary neurological disorder affecting coordination and movement in Kerry Blue Terriers. Early genetic testing helps identify carriers and affected dogs, enabling responsible breeding decisions. By using the CMSD DNA test, breeders can reduce the risk of passing this debilitating condition to future generations. This test provides accurate, reliable results, promoting the well-being of your Kerry Blue Terrier. Protect your dog’s health with the CMSD DNA test today. Regular screening supports a healthier, happier canine companion.
Canine Multiple System Degeneration (CMSD) is a genetic disorder affecting Kerry Blue Terriers, causing progressive neurological decline. A DNA test is available to identify carriers and affected dogs, helping breeders make informed decisions. Early detection through testing can prevent the spread of this debilitating condition within the breed. Responsible breeding practices rely on these genetic insights to maintain healthy Kerry Blue Terrier populations. Overall, the CMSD DNA test is a valuable tool for canine health management.
Ko e sivi DNA ko eni 'oku kau ia 'o kamata mei he'etau pack . Basic — pea ko e konga foki ia 'o e ngaahi pack . Basic, Standard, Advanced, Complete.
Vakai ki he Ngaahi Pack Sivi DNA →Canine Multiple System Degeneration (CMSD) is a progressive neurological disorder that primarily affects Kerry Blue Terriers. This condition is characterized by the degeneration of multiple systems within the nervous system, leading to a range of debilitating symptoms that can significantly impact the quality of life of affected dogs.
The symptoms of CMSD-KBT typically manifest in early to mid-adulthood, although the age of onset can vary. Common signs include balance problems, difficulty walking, and a general lack of coordination. As the disease progresses, affected dogs may exhibit muscle weakness, tremors, and a decline in overall mobility. In some cases, dogs may also experience changes in behavior, such as increased anxiety or a reluctance to engage in normal activities.
The underlying cause of CMSD-KBT lies in genetic mutations that affect the nervous system's ability to function properly. These mutations lead to the degeneration of nerve cells, which in turn causes a breakdown of communication between the brain and the body. This disruption results in the clinical symptoms observed in affected dogs. Understanding the genetic basis of CMSD-KBT is crucial for breeders and owners, as it allows for informed decisions regarding breeding practices and the management of affected animals.
While there is currently no cure for CMSD-KBT, management strategies can help improve the quality of life for affected dogs. Regular veterinary check-ups are essential for monitoring the progression of the disease and addressing any health concerns that arise. Physical therapy and rehabilitation exercises can assist in maintaining mobility and strength. Additionally, providing a safe and supportive environment can help dogs cope with their symptoms and enhance their overall well-being.
Canine Multiple System Degeneration in Kerry Blue Terriers is a serious condition that requires attention from dog owners and breeders. By understanding the symptoms, underlying causes, and management strategies associated with CMSD-KBT, stakeholders can work towards improving the lives of affected dogs while making informed breeding decisions to reduce the prevalence of this condition in the breed.
‘Oku ‘ikai ke ‘ave ‘e he manú ‘a e mutation. He ʻikai ke ne maʻu ʻa e mahakí . pea ‘e ‘ikai te ne paasi atu ia.
Ikai ‘Oku mo‘ui lelei fakalūkufua ‘a e manú ka ‘oku lava ke ne fakahoko ‘a e mutation ki hono . hako.
‘Okú ne ‘ave ha ongo tatau kuo liliu. 'Oku 'amanaki ke 'asi mai 'a e ngaahi faka'ilonga fakafaito'o 'o makatu'unga 'i he . ko e mahaki. ʻOku ʻikai totonu ke fakatupu ia.
Ko e ngaahi mahaki ‘e ni‘ihi ‘oku fehokotaki ia mo e fehokotaki fakasinó, ko ia ‘oku kehekehe ‘enau fakahaa‘í ‘o fakatatau ki he . fehokotaki fakasino ‘o e monumanu.
This DNA test detects the mutation associated with Canine Multiple System Degeneration In Kerry Blue Terrier (CMSD-KBT) in order to identify clear, carrier, or at-risk animals.
‘Oku tokoni‘i ‘e he sivi DNA ‘a e kau tauhí ke nau palani ‘a e ngaahi fehokotaki malu ange pea fakasi‘isi‘i ‘a e fakatu‘utāmaki ‘o hono fakahoko ‘o e mutation ki he fānaú.
Ko e founga tofi'a 'oku lipooti ki he sivi ko 'eni ko e Autosomal Recessive.
This test analyses the mutation SERAC1 c.1536G>A.
ʻOku ʻikai pau. 'Oku makatu'unga 'a e faka'uhinga 'i he founga 'o e tofi'a mo e genotype 'oku ma'u mei ai.
Johnson GS, Mhlanga-Mutangadura T, Morava E, Kozicz T, Taylor JF, O’Brien DP, Schnabel RD. Canine Multiple System Degeneration is Associated with Distinct SERAC1 Mutations in Two Different Dog Breeds [abstract]. Presented at the 63rd Annual Meeting of the American Society of Human Genetics in Boston, Massachusetts; 2013 Oct 22-26.
Ko ho'o fakapulipuli, ko ho'o fili .
'Oku mau faka'aonga'i 'a e ngaahi kuki mahu'inga ke fakalele 'a e uepisaiti. Ko e ngaahi kuki fili (hange ko e kau foaki 'o e ngaahi me'a 'oku fakahu) 'oku fakata'e'aonga'i 'e he default pea 'oku toki faka'ata pe kapau 'oku ke loto ki ai. Te ke lava ʻo liliu hoʻo filí ʻi ha taimi pē ʻo fakaʻaongaʻi ʻa e “Kuki” button.
Fiema'u ki he ngaahi tefito'i me'a mo e malu. Fakaʻatā maʻu pē.
Fakalelei'i 'a e ngaahi me'a hange ko e fakahaofi 'o e manako pe 'ikai faka'ilo embeds.
Tokoni ke mahino kiate kitautolu hono faka'aonga'i 'o e saiti. Fakata'e'aonga'i 'e he default.
Faka'ilo/muimui'i 'i he ngaahi saiti ('oku fakahu 'e he vitio/mape 'e ni'ihi). Fakata'e'aonga'i 'e he default.